Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2008
10/02/2008WO2008117037A1 Co-crystals of propiconazole
10/02/2008WO2008116671A1 2,3,4,9-tetrahydro-1h-carbazoles
10/02/2008WO2008116670A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases
10/02/2008WO2008116669A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
10/02/2008WO2008116620A1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/02/2008WO2008099076A3 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
10/02/2008WO2008097640A3 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
10/02/2008WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors
10/02/2008WO2008071951A3 Catalytic process for asymmetric hydrogenation
10/02/2008WO2008059259A3 Anticancer compounds with a benzo ( 1, 2, 4 ) triazin-3yl-amine core
10/02/2008WO2008043996A3 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
10/02/2008WO2007139968A3 Triazole compounds that modulate hsp90 activity
10/02/2008WO2007082098A8 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
10/02/2008US20080242714 alpha -[hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octenyl)-2H-cyclopenta[b]furan-2-ylidene]-1H-tetrazole-5-2E-pentanenitrile; inhibits release of Th-1 cytokines while sparing expression of Th-2 cytokines; viricide; respiratory diseases associated with influenza A viruses
10/02/2008US20080242713 alpha -[hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octenyl)-2H-cyclopenta[b]furan-2-ylidene]-1H-tetrazole-5-2E-pentanenitrile; inhibits release of Th-1 cytokines while sparing expression of Th-2 cytokines; multiple sclerosis, psoriasis, rheumatoid arthritis, Crohn's disease, alopecia areata
10/02/2008US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis
10/02/2008US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
10/02/2008US20080242676 Drug resistant Mycobacterium tuberculosis
10/02/2008US20080242658 Inhibitors of Iap
10/02/2008CA2681591A1 Pulverized crystals of olmesartan medoxomil
10/02/2008CA2681431A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of .beta.-secretase
10/02/2008CA2681379A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
10/02/2008CA2681206A1 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/02/2008CA2680351A1 Co-crystals of propiconazole
10/01/2008EP1975163A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
10/01/2008EP1975159A1 2,3,4,9-Tetrahydro-1H-carbazoles
10/01/2008EP1974608A1 Arylpyridazines as fungicides
10/01/2008EP1973918A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/01/2008EP1973905A1 Compounds
10/01/2008EP1973902A2 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
10/01/2008EP1973900A1 Hydantoin compounds for the treatment of inflammatory disorders
10/01/2008EP1973886A2 Prokineticin 1 receptor antagonists
10/01/2008EP1973881A2 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
10/01/2008EP1565456B1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
10/01/2008EP1420780B1 Cyclopropyl and cyclobutyl epothilone analogs
10/01/2008CN101277951A 2-aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
10/01/2008CN101277945A Indol-3-yl-carbonyl-piperidin and piperazin derivatives
10/01/2008CN101274929A Thrombin receptor antagonists
10/01/2008CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/01/2008CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/01/2008CN100422158C Inhibitors of Akt activity
10/01/2008CN100422156C Isoquinolinium compound, producing method and application of its salt
10/01/2008CN100422151C Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/01/2008CN100421665C Mitotic kinesin inhibitors
09/2008
09/30/2008USRE40525 Hepatitis C inhibitor tri-peptides
09/30/2008US7429609 Pyrazole compound and medicinal composition containing the same
09/30/2008US7429603 C-fms kinase inhibitors
09/30/2008US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents
09/30/2008US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
09/30/2008US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors
09/30/2008US7429593 Utilities of amide compounds
09/30/2008US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor
09/30/2008US7429579 antagonism/inhibition, of the D3 receptor; substance abuse.
09/30/2008CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/30/2008CA2314009C Triazole and imidazole derivatives
09/30/2008CA2303848C Substituted anilides
09/25/2008WO2008116185A2 Substituted pyrimidines as adenosine receptor antagonists
09/25/2008WO2008115369A2 Inhibitors of focal adhesion kinase
09/25/2008WO2008114272A2 Process for preparing alpuzosin and crystalline alfuzosin hydrochloride
09/25/2008WO2008114023A2 Phthalazinone derivatives
09/25/2008WO2008094574A3 Furanone compounds and methods of making and using the same
09/25/2008WO2007120655A3 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
09/25/2008US20080234481 Forming salts such as tartrate or mandelate ; chemical intermediate
09/25/2008US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
09/25/2008US20080234287 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide
09/25/2008US20080234250 Heterocyclic Condensed Compounds Useful as Antidiuretic Agents
09/25/2008US20080234248 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia
09/25/2008US20080234247 Heterocyclic analgesic compounds and methods of use thereof
09/25/2008CA2681516A1 Compounds useful as inhibitors of janus kinases
09/25/2008CA2681015A1 Inhibitors of focal adhesion kinase
09/24/2008EP1972623A1 Arylpyridazines as fungicides
09/24/2008EP1971598A1 Beta-secretase modulators and methods of use
09/24/2008EP1971576A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
09/24/2008EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
09/24/2008EP1513520B1 Substituted pyrrolines as kinase inhibitors
09/24/2008EP1381599B1 Quinazoline derivatives
09/24/2008EP1322650B1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
09/24/2008CN101273035A Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
09/24/2008CN101273034A Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
09/24/2008CN101273016A Antibacterial quinoline derivatives
09/24/2008CN101270116A Neutral-amphiprotic bond-connection type second order nonlinear optics chromogen and synthesizing process thereof
09/23/2008US7427683 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer
09/23/2008US7427682 Indole derivatives as selective androgen receptor modulators (SARMS)
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427631 especially as inhibitors of MMP12
09/23/2008US7427620 4-{4-[4-{4-[2-(2-pyridinyl)-2-(1 H-1,2,4-triazol- 1 -yl-methyl)- 1 ,3-dioxolan-4-yl-methoxy]phenyl}- 1-piperazinyl]-phenyl}-2-( 1-methyl)-propyl-2,4-dihydro-3H-1,2,4-triazol-3-one; better toxicological profile and of reduced interaction with other drugs; good solubility in water, bioavailability
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2395541C New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them
09/23/2008CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/23/2008CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
09/23/2008CA2293373C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
09/23/2008CA2198238C Piperidine derivatives as neurokinin antagonists
09/18/2008WO2008112900A1 Dibenzo[b,f][1,4]oxazapine compounds
09/18/2008WO2008112440A1 Piperazine and piperidine mglur5 potentiators
09/18/2008WO2008111473A1 Glucokinase activator
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008110863A1 Indazole derivatives and their use as vanilloid receptor ligands
09/18/2008WO2008110611A1 Organic compounds and their uses
1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 694